WHO European health information at your fingertips.

Indicator is part of data set(s):

HFA-DB

Indicator full name: Disability-adjusted life expectancy, males

Unit: years

Dimensions:

Country/Area (COUNTRY/AREA)
Supranational group of countries (COUNTRY_GRP)
Sex (SEX)
Year of measure (YEAR)

Years data is available: 2000—2015

Last updated: 21 October 2025

(Sub)regional averages available for:

Members of the EU before Feb 2020
Western Balkans

Export to:

HFA-DB

European Health for All database

Indicators: 618

Updated: 21 October 2025

Contact: Data, Artificial Intelligence and Digital Health unit (DAD)

The following abbreviations are used in the indicator titles:

• SDR: age-standardized death rates (see HFA-DB user manual/Technical notes, page 13, for details)

• FTE: full-time equivalent

• PP: physical persons

• PPP$: purchasing power parities expressed in US $, an internationally comparable scale reflecting the relative domestic purchasing powers of currencies.

Indicator notes

WHO Global Health Estimates provide a comprehensive and comparable set of DALY estimates from year 2000 onwards. The sum of these DALYs across the population, or the burden of disease, can be thought of as a measurement of the gap between current health status and an ideal health situation where the entire population lives to an advanced age, free of disease and disability.

DALYs for a disease or health condition are calculated as the sum of the Years of Life Lost (YLL) due to premature mortality in the population and the Years Lost due to Disability (YLD) for people living with the health condition or its consequences.

Because these estimates draw on new data and on the results of the GBD 2015 study, and there have been substantial revisions to methods for many causes, these estimates for the years 2000-2015 are not directly comparable with previous WHO estimates of DALYs.

For more detailed information on the methods used to calculate disability-adjusted life expectancy, see http://www.who.int/healthinfo/global_burden_disease/GlobalDALYmethods_2000_2015.pdf?ua=1

Country/Area notes

No information

General notes

What is Disability-Adjusted Life Expectancy for Males?

Disability-Adjusted Life Expectancy (DALE) for males is a health metric that quantifies the overall burden of disease and disability on the life expectancy of males. It reflects the number of years a male can expect to live in full health by subtracting the years of ill health, weighted by severity, from the overall life expectancy. This indicator is crucial for understanding the health challenges that males face across different regions and for evaluating the effectiveness of health systems in addressing these challenges.

The Importance of Disability-Adjusted Life Expectancy for Males

Understanding the Disability-Adjusted Life Expectancy for males is vital for policymakers, health professionals, and researchers. It helps in identifying critical health issues affecting male populations and facilitates the allocation of resources to where they are most needed. For instance, if a particular region shows a low DALE for males, it might indicate underlying problems such as poor access to medical care or high prevalence of specific diseases, guiding targeted health interventions. Additionally, this metric is essential for monitoring progress in health policies and comparing health outcomes between different populations and over time.

Strengths and Limitations of Disability-Adjusted Life Expectancy for Males

While Disability-Adjusted Life Expectancy for males is a valuable tool in public health, it comes with its own set of strengths and limitations.

Strengths

One of the primary strengths of DALE for males is its ability to provide a more comprehensive picture of health than traditional life expectancy. By accounting for the quality of life, not just the quantity, it allows for a deeper understanding of the true health status of male populations. This metric is particularly useful for health comparisons across different countries and regions, facilitating global health strategies and interventions.

Limitations

However, the calculation of DALE for males also faces several challenges. The accuracy of this metric heavily depends on the quality and availability of data on morbidity and mortality, which can vary significantly between regions. In some areas, especially in low-resource settings, data may be incomplete or unreliable, leading to potential inaccuracies in the estimated DALE. Moreover, DALE does not account for the socioeconomic factors that may influence health outcomes, nor does it reflect short-term fluctuations caused by epidemics or disasters, which can temporarily alter the health landscape.

In conclusion, while Disability-Adjusted Life Expectancy for males is an insightful and useful health indicator, it must be interpreted with an understanding of its complexities and limitations. It remains a crucial tool in the arsenal of public health professionals, aiding in the formulation of more effective health policies and programs tailored to the specific needs of male populations worldwide.